680
Participants
Start Date
October 12, 2022
Primary Completion Date
December 30, 2025
Study Completion Date
June 30, 2026
Progesterone-IBSA Injectable Solution
Progesterone-IBSA 25mg, twice daily (BID) SC Injection every 12 hours
Progesterone Vaginal Gel with Applicator
Crinone 8%, 90 mg, QD intravaginally
Placebo Vaginal gel with applicator
Vaginal gel Placebo, once daily (QD) intravaginally
Placebo injectable solution
Placebo injectable solution, BID SC Injection every 12 hours
Main Line Fertility, Bryn Mawr
Shady Grove Fertility, Chesterbrook
Reproductive Associates of Delaware, Newark
Johns Hopkins Fertility Center, Lutherville
Carolina Conceptions, Raleigh
Reproductive Endocrinology Associates of Charlotte, Charlotte
The IVF Center, Winter Park
IVF Florida Reproductive Associates, Margate
Women's Medical Research Group, LLC, Clearwater
Institute for Reproductive Health, Cincinnati
InVia Fertility Specialists, PLLP, Hoffman Estates
Care Fertility, Bedford
Aspire Houston Fertility Institute, Houston
Center of Reproductive Medicine, LLC., Shady Grove Fertility, Webster
Utah Fertility Center, PC, Pleasant Grove
The Fertility Treatment Center, LLC, Tempe
Kindbody, Los Angeles
HRC Fertility, Encino
San Diego Fertility, San Diego
Spring Fertility, San Francisco
Illume Fertility, Norwalk
University Reproductive Associates, PC, Hasbrouck Heights
Lead Sponsor
IBSA Institut Biochimique SA
INDUSTRY